These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8633392)

  • 1. Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy.
    Wu CS; Pollack A; Czerniak B; Chyle V; Zagars GK; Dinney CP; Hu SX; Benedict WF
    Urology; 1996 Mar; 47(3):305-10. PubMed ID: 8633392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.
    Cole CJ; Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):331-40. PubMed ID: 7751174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer.
    Pollack A; Czerniak B; Zagars GK; Hu SX; Wu CS; Dinney CP; Chyle V; Benedict WF
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):687-95. PubMed ID: 9336151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer.
    Chyle V; Pollack A; Czerniak B; Stephens LC; Zagars GK; Terry NH; Meyn RE
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):281-7. PubMed ID: 8635934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of local control to distant metastasis in muscle invasive bladder cancer.
    Pollack A; Zagars GK; Cole CJ; Dinney CP; Swanson DA; Grossman HB
    J Urol; 1995 Dec; 154(6):2059-63; discussion 2063-4. PubMed ID: 7500458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.
    Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
    Cancer; 1994 Nov; 74(10):2819-27. PubMed ID: 7954243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of downstaging in muscle-invasive bladder cancer treated with preoperative radiotherapy.
    Pollack A; Zagars GK; Cole CJ; Dinney CP; Swanson DA; Grossman HB
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):41-9. PubMed ID: 9054875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for stage T3b transitional cell carcinoma of the bladder.
    Pollack A; Zagars GZ
    Semin Urol Oncol; 1996 May; 14(2):86-95. PubMed ID: 8734736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.
    Ong F; Moonen LM; Gallee MP; ten Bosch C; Zerp SF; Hart AA; Bartelink H; Verheij M
    Radiother Oncol; 2001 Nov; 61(2):169-75. PubMed ID: 11690683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal bcl-2 and pRb expression are independent correlates of radiation response in muscle-invasive bladder cancer.
    Pollack A; Wu CS; Czerniak B; Zagars GK; Benedict WF; McDonnell TJ
    Clin Cancer Res; 1997 Oct; 3(10):1823-9. PubMed ID: 9815569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy.
    Hemal AK; Khaitan A; Dinda AK; Gupta NP; Seth A; Dogra PN; Nabi G
    Urol Int; 2003; 70(1):42-6. PubMed ID: 12566814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
    Moonen L; Ong F; Gallee M; Verheij M; Horenblas S; Hart AA; Bartelink H
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1305-10. PubMed ID: 11286838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement.
    Frank I; Cheville JC; Blute ML; Lohse CM; Karnes RJ; Weaver AL; Sebo TJ; Nehra A; Zincke H
    Cancer; 2004 Oct; 101(8):1803-8. PubMed ID: 15386300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
    Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
    J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
    Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
    J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of lymph node metastasis based on p53 and nm23-H1 expression in muscle invasive grade III transitional cell carcinoma of bladder.
    Park DS; Lee YT; Lee JM
    Adv Exp Med Biol; 2003; 539(Pt A):67-85. PubMed ID: 15088897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the combined expression of tumor-associated trypsin inhibitor (TATI) and p53 in patients with bladder cancer undergoing radical cystectomy.
    Liu A; Xue Y; Liu F; Tan H; Xiong Q; Zeng S; Zhang Z; Gao X; Sun Y; Xu C
    Cancer Biomark; 2019; 26(3):281-289. PubMed ID: 31594208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
    Chauvet B; Brewer Y; Félix-Faure C; Davin JL; Choquenet C; Reboul F
    J Urol; 1996 Oct; 156(4):1258-62. PubMed ID: 8808849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
    Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
    Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder.
    Glick SH; Howell LP; White RW
    J Urol; 1996 May; 155(5):1754-7. PubMed ID: 8627878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.